Nathaniel P. Gallon
Nate Gallon has spent his entire legal career in Silicon Valley working within the technology community, representing entrepreneurs, start-ups, emerging growth companies, major corporations, and the entire ecosystem of the investor community that funds and supports these innovators.
Nate works with his clients to understand their needs and business objectives and develops practical solutions to help them achieve their goals. He counsels his clients on corporate and securities law and also acts more generally as a trusted business advisor in connection with a wide range of transactions that technology companies typically undertake throughout their life cycle — entity formation, debt and equity financings, recapitalizations, joint ventures, spin-offs, and growth stage through to a liquidity event.
During his time in Silicon Valley, Nate has developed a network of entrepreneurs, investors, and advisors that allows him to stay current on the latest technology trends and priorities for venture capital firms, angels, and other investors as well as acquirers of technology companies. He has represented hundreds of start-ups and entrepreneurs in connection with equity financings and general corporate matters, worked on numerous M&A transactions (including buy- and sell-side mergers, asset sales, and stock purchase transactions), and advised a number of public company clients on corporate finance and capital raising transactions, including public offerings, private placements, and PIPES.
Nate joined Hogan Lovells in 2014. Previously he was a partner at another California-based global firm.
Represents several major corporations in connection with their ongoing equity investments in U.S. private companies.
Represents DAG Ventures in connection with a number of venture capital transactions.
Has represented Insikt, Inc in connection with successive rounds of equity financings.
Has represented Picatcha, Inc. in connection with successive rounds of equity financings.
Has represented Cure Forward, Inc. in connection with successive rounds of equity financings.
Represented MTS Health Investors in connection with several equity investments.